NCI Precision Medicine Study Hones in on Cancer Remission
Researchers say a non-chemotherapy treatment is causing more cancer patients to experience full remission.
A recent National Cancer Institute study shows that a new targeted therapy can help prolong the time cancer patients are in remission. Called the ViPOR regimen, the non-chemotherapy treatment shrinks tumors of those who suffer from B-cell lymphoma.
Dr. Christopher Melani, associate research physician with the Lymphoid Malignancies Branch in the Center for Cancer Research at NCI, highlights the importance of combining five therapies and administering them during a fixed cycle to maximize drug synergy and make tumors disappear.
He also shares details about the second phase of the study that is expected to take place later this year as well as how precision medicine could potentially lead to a cure for all types of cancer.
-
Dr. Christopher Melani Associate Research Physician, Lymphoid Malignancies Branch, Center for Cancer Research NCI
-
How Edge AI Is Shaping the Future of Federal Missions
HP's Leif Olson discussed how edge AI can help federal agencies strengthen security, control costs and improve mission efficiency.
9m watch -
AI Drives Cybersecurity Strategies Beyond Patching to Thwart Vulnerabilities
NinjaOne's Egon Rinderer discussed how AI-driven cyber threats are changing vulnerability management and why agencies need to move beyond patching.
20m watch -
How Zero Trust Can Help Agencies Secure Emerging AI Capabilities
Island's Monty Montgomery discussed how zero trust can help federal agencies secure AI systems and manage emerging risks.
6m watch -
VA Aims to Build a More Connected Digital Experience for Veterans
Officials outlined progress on EHR modernization, VA.gov updates and digital identity verification to improve veterans’ access to benefits.
4m read